関連する実験動画
Updated: Jun 23, 2026

14:57
Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
TIGARは,glycolysisとapoptosisのp53-誘導性レギュレータであり,その作用を抑制している
Karim Bensaad1, Atsushi Tsuruta, Mary A Selak
1The Beatson Institute for Cancer Research, Switchback Road, Glasgow G61 1BD, UK.
Cell
|July 15, 2006
まとめ
腫瘍抑制剤p53は,TIGAR遺伝子を介して細胞死を調節する. TIGARは活性酸素種 (ROS) と糖分解を減少させ,p53誘発のアポトーシスとゲノム損傷から細胞を保護します.
科学分野:
- 分子生物学は分子生物学である.
- がん研究 がん研究
- 細胞の代謝について
背景:
- 腫瘍抑制タンパク質p53は,がんの予防に不可欠です.
- p53は,細胞サイクル停止,アポトーシス,およびゲノム安定性の維持を通じて機能します.
研究 の 目的:
- 新しいp53-誘導性遺伝子を特定する.
- p53媒介の細胞応答におけるTIGAR (TP53誘発の糖分解およびアポトーシス調節体) の役割を調査する.
主な方法:
- p53誘導性の遺伝子発現の分析.
- 果糖-2,6-ビスホスファートと細胞内活性酸素種 (ROS) のレベルを測定する.
- 細胞アポトーシスとp53誘発死亡に対する感受性の評価.
主要な成果:
- TIGARをp53誘導性遺伝子として特定しました.
- TIGAR発現はフルークトーゼ-2,6-ビスホスファートを減少させ,グリコリシスを阻害し,細胞内ROSを低下させた.
- TIGARはROSに関連したアポトーシスから細胞を保護し,TIGARのノックダウンによりp53誘発による死亡に細胞を敏感にします.
結論:
- TIGARはp53に対するアポプトシス反応を調節し,ストレス下での細胞生存を促進します.
- TIGARによる細胞内ROSの減少は,ゲノム損傷を防ぐp53の役割に貢献する.
関連する概念動画
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...

